Biotech Acurx Pharmaceuticals, Inc. Announces Closing of up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules April 17, 2026
Biotech Adcendo ApS Completes $75 Million Series C Financing to Continue Advancing First- and Best-in-class Clinical ADC Pipeline April 14, 2026
Biotech Lundbeck to showcase new neurology data at the American Academy of Neurology Annual Meeting April 13, 2026
Biotech Miracell Receives FDA 510(k) Clearance for SMART M-CELL PRP Concentration System and SMART M-CELL Bone Marrow Concentration System April 12, 2026
Biotech Biotechs Racing to Translate Longevity Science Into Real Therapies — And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells April 11, 2026
Biotech Oricell Therapeutics Closes $110 Million Pre-IPO Financing to Accelerate Global Development of Solid Tumor CAR-T Therapies April 10, 2026